BABA-W (9988.HK) › Analysis

BABA-W (9988.HK) stock analysis, January 26, 2026: BABA pulls back to $164.90, but can it hold $160 support?

Published January 26, 2026 · 9988.HK chart, levels and live analysis

Key Updates

BABA-W declined 2.14% to $164.90 since the January 24th report, pulling back from the $168.50 breakout level amid a modest consolidation. The pullback follows two significant news developments: continued legal investigations regarding alleged military technology support claims, and confirmation of plans to spin off T-Head chipmaking unit via IPO. Despite the near-term weakness, the stock maintains its strong uptrend with YTD gains of 15.64% and 6-month gains of 39.75%, holding well above the $160 support level established in mid-January.

Current Trend

BABA-W remains in a robust uptrend with YTD performance of +15.64% and exceptional 6-month gains of +39.75%. The stock has established a clear support zone at $157-160, tested twice in January without breaking, while resistance at $168-170 has proven more challenging. The recent 2.14% decline represents normal consolidation following the 7.32% surge to $168.50 on January 24th. Monthly momentum remains strong at +12.87%, and the 5-day performance of +2.81% confirms buyers remain active on dips. The technical structure shows higher lows throughout January ($142 → $157 → $160), indicating sustained accumulation despite intermittent profit-taking.

Investment Thesis

The investment thesis centers on Alibaba's strategic transformation into an AI-first technology conglomerate, supported by CEO Eddie Wu's $53+ billion commitment to AI infrastructure. The company is executing a multi-pronged strategy: monetizing AI chip technology through T-Head's planned IPO, integrating AI capabilities across its ecosystem via the Qwen platform (100 million users), and leveraging healthcare AI applications through Alibaba Health. Access to Nvidia H200 chips positions Alibaba to compete with OpenAI and other global AI leaders, while the domestic chip development through T-Head provides strategic independence from U.S. technology restrictions. The core e-commerce business provides stable cash flows to fund aggressive AI investments, creating optionality for multiple value creation pathways.

Thesis Status

The investment thesis is strengthening despite near-term noise. The T-Head IPO planning represents tangible progress in monetizing AI chip technology and validates the strategic value of Alibaba's semiconductor investments. This move follows strong investor demand for Chinese chip IPOs (MetaX, Moore Threads), suggesting favorable market conditions for the offering. However, the ongoing securities fraud investigation regarding alleged military technology support introduces regulatory and reputational risk that could constrain valuation multiples. The thesis remains intact as operational execution continues unimpeded, but geopolitical headwinds require monitoring. The 39.75% six-month rally reflects growing market confidence in the AI transformation strategy.

Key Drivers

T-Head IPO Preparation: Alibaba is restructuring its chipmaking unit T-Head as a partially employee-owned business ahead of a potential IPO, capitalizing on strong investor demand for AI accelerator companies. T-Head produces the Hanguang 800 AI inference chip deployed across Alibaba Cloud, Tmall, and Alimama, and recently secured a contract with China Unicom for data center deployment. The timing remains undetermined, but the restructuring represents the initial step toward unlocking value from Alibaba's semiconductor investments.

Legal Investigation Overhang: Pomerantz Law Firm continues investigating potential securities fraud claims following November 2025 Financial Times reports of a White House memo alleging Alibaba provided technological support for Chinese military operations. This investigation, while not yet materialized into formal charges, creates headline risk and potential class action exposure that could pressure the stock intermittently.

AI Infrastructure Buildout: Previous reports confirmed China's approval of Nvidia H200 chip imports and Alibaba's interest in ordering 200,000+ units, Qwen app integration with Taobao/Alipay reaching 100 million users, and Alibaba Health's 19% surge on AI healthcare applications. These initiatives continue progressing, supported by the $53+ billion AI investment commitment.

Technical Analysis

BABA-W trades at $164.90, down 2.14% from the $168.50 level reached on January 24th. The stock has established a well-defined support zone at $157-160, tested on January 21st ($157.00) and defended successfully. Resistance remains at $168-170, representing the October 2025 peak levels and the recent January 24th high. The pullback from $168.50 to $164.90 shows healthy profit-taking rather than distribution, with volume patterns suggesting accumulation on dips. Key technical levels: immediate support at $160, secondary support at $157, resistance at $168, and breakout target at $175+ if $170 is cleared. The stock maintains a higher-low pattern throughout January, and the 5-day gain of +2.81% indicates buyers remain engaged despite the 1-day decline.

Bull Case

Bear Case

Get a message when the 9988.HK picture changes — the agent team watches the levels and the news for you.Create a free account

More 9988.HK analyses